Why Colon Cancer Screening Now Starts at Age 45: What This Means for You

Colon Cancer Screening
Print icon

When it comes to colon cancer screening, 45 is the new 50.

The latest American Cancer Society guideline for colorectal cancer screening, established in 2018, recommends that average-risk adults age 45 and older undergo regular screening. The previous guideline recommended that people without symptoms and without a family history of the disease wait until age 50 before undergoing a colonoscopy or similar screening.

Why the change?

Screening Tests and What the Results Mean:

It’s mainly due to the rise in colon cancer in younger patients, according to Hartford HealthCare gastroenterologist Dr. Thomas Feldman.

“There’s been a significant increase — as much as a 50 percent increase in the last two decades — in colon cancers in those under age 45,” said Dr. Feldman. “It’s rather shocking. Patients who used to come in with minor complaints are now pursued much more aggressively because of these concerns.”

The reason for the increase?

“No one really knows,” he said.

Dr. Feldman’s colleague, gastrointerologist Dr. Neil Parikh, adds that there is a specific reason the age has been lowered to 45.

“Most of those patients that do get colon cancer before the age 50, it’s happening between ages 45 and 49,” Dr. Parikh said. “So these guidelines catch that population.”

Dr. Feldman emphasizes that colon cancer screenings, such as colonoscopies, work well to find colon cancer so it may be treated before it’s too late.

“The best screening is the one that gets done on time,” he said.

And now, “on-time” means, for most of us, age 45.

For more information, please call 1.855.HHC.HERE


What's New


Manchester Facility Brings Cancer, Other Services ‘East of the River’

Seeking to bring high-quality healthcare closer to people east of Hartford, Hartford HealthCare this month opened a $10.4-million, three-story building focused on delivering advanced cancer services and treatment while including the care of general and thoracic surgeons and urologists. “We know that bringing comprehensive cancer services into the community allows...

Cancer

Another New Cancer Drug Targets Tumors Based on Genetic Makeup

For the second time, the Food and Drug Administration has approved a drug treatment for patients with a specific genetic change in their tumor, regardless of the type of cancer. At Hartford Healthcare, Laila Mnayer, division director of Molecular Pathology and Cytogenetics, had already identified the importance of these fusion...

HPV

Ask a Doctor About HPV at These Free Seminars

Healthwise If You Have Symptoms When to Talk to Your Doctor Free Educational Seminars Learn more about HPV at one of these free educational seminars: Wednesday, March 27, at 5:30 p.m.: Gateway Medical Park (Education Room), 305 Western Blvd., Glastonbury. Click here to register. Wednesday, March 27, at 6:30 p.m.: Backus Hospital Main Lobby...


‘One for Everyone’ Donates to Avon Cancer Center

“What do we have in excess?” That was the simple question posed by a group of Avon seventh graders who had formed a charitable organization called One for Everyone. When the group was organized five years ago, the youth wanted to help those less fortunate but didn’t know what would...

HOCC adds endocrine surgeon.

Hospital of Central Connecticut Adds Dr. Carrie Carsello, Endocrine Surgeon

NEW BRITAIN – The Hospital of Central Connecticut (HOCC) has announced the addition of endocrine surgeon Dr. Carrie Carsello.  She is the only Hartford HealthCare surgeon who is fellowship trained in endocrine surgery, which treats conditions thyroid cancer, thyroid nodules, goiters, hyperparathyroidism, Graves’ disease and nodules, tumors, and cancer of...